Idexx Laboratories | IDXX - Current Liabilities


Idexx Laboratories reported $1.26B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Abbott USD 16.15B 1.66B Sep/2026
Accuray USD 199.44M 4.83M Dec/2025
Align Technology USD 1.91B 4.9M Sep/2026
AngioDynamics USD 71.96M 3.68M Sep/2025
Dentsply International USD 1.22B 32M Sep/2026
Dexcom USD 2.25B 105.1M Sep/2026
Edwards Lifesciences USD 1.58B 68.8M Sep/2026
Fujifilm JPY 1.35T 95.27B Sep/2026
Globus Medical USD 507.94M 28.59M Sep/2026
Henry Schein USD 3.6B 110M Sep/2026
Idexx Laboratories USD 1.26B 23.44M Sep/2026
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 814.4M 70.2M Sep/2026
Integra LifeSciences USD 329M 1.88M Sep/2026
Intuitive Surgical USD 3.23B 652.4M Sep/2026
Neogen USD 149.5M 8.7M Jun/2026
Orthofix International USD 138.38M 18.62M Sep/2026
Phibro Animal Health USD 295.79M 20.68M Sep/2026
ResMed USD 1.32B 70.89M Sep/2026
Roche Holding CHF 28.85B 846M Jun/2026
Steris USD 1.21B 75.5M Sep/2026
Tandem Diabetes Care USD 256.08M 3.07M Sep/2026
Teleflex USD 917.1M 196.72M Sep/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Zoetis USD 2.68B 621M Sep/2026